116 related articles for article (PubMed ID: 32027262)
1. [LY294002 Enhaces Chemosensitivity of K562 Cells to Daunorubicin].
Geng YH; Wu WJ; Li J; Zhou LL; Yang YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):110-118. PubMed ID: 32027262
[TBL] [Abstract][Full Text] [Related]
2. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
3. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
Jiang HN; Liu ZG; Hu R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
[TBL] [Abstract][Full Text] [Related]
4. [Navitoclax Combined with Daunorubicin Promotes Apoptosis of Erythroleukemia Cell Lines K562, HEL and TF-1].
Duan YJ; Liu C; Chen XY; Wu WQ; Zheng JR; Zhang YC; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):724-730. PubMed ID: 32552927
[TBL] [Abstract][Full Text] [Related]
5. [Effect of
Wang J; Wang ZJ; Li ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):45-51. PubMed ID: 38387898
[TBL] [Abstract][Full Text] [Related]
6. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
Xie X; Tang B; Zhou J; Gao Q; Zhang P
Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
[TBL] [Abstract][Full Text] [Related]
8. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
[TBL] [Abstract][Full Text] [Related]
9. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215
[TBL] [Abstract][Full Text] [Related]
10. [Combined effect of recombinant mutant human TRAIL and daunorubicin in inducing apoptosis of leukemia cell and its mechanism].
Zhang XJ; Wen L; Wang FX; Luo JM; Pan L; Liu XJ; DU XY; Dong ZR; Yang SF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1123-8. PubMed ID: 17204177
[TBL] [Abstract][Full Text] [Related]
11. [Effects of matrine combined with LY294002 on proliferation, apoptosis and cell cycle of human myeloid leukemia K562 cells].
Hao Y; Ji J; Liu C; Zhang N; Gong Y
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1739-1746. PubMed ID: 36504069
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
[TBL] [Abstract][Full Text] [Related]
13. [Relationship of PTEN/PI3K/AKT Signaling Pathway Protein Expression with Apoptosis and Drug-resistance of Children's ALL Primary Cells Treated with Daunorubicin].
Yang L; Li JJ; Cheng YY; Lu WJ; Wang Z; Tao F; Li JX; Xu ZL; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1053-1057. PubMed ID: 31418356
[TBL] [Abstract][Full Text] [Related]
14. [The Mechanism of Artesunate Combined with Cytarabine and/or Daunorubicin on the Apoptosis of MV4-11 MLL-rearranged Acute Myeloid Leukemia Cell Line].
Li JY; Xiong X; Wang DW; Zhang XY; Huang C; Zou LL; Zheng CF; Chen X; Tu CQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1724-1729. PubMed ID: 36476895
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Huaier Aqueous Extract Combined with Routine Chemo-therapeutic Drugs on Human Acute Lymphoblastic Leukemia Cells Nalm-6 and Sup-B15].
Qu P; Zhou F; Tan LF; Wang ZJ; Wang ML; Jin RM; Han J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1451-1458. PubMed ID: 33067936
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis-Inducing Effect of Ginsenoside Rh2 on Human Acute T Lymphoblastic Leukemia Jurkat Cells and Its Mechanism].
Nie L; Peng HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1111-1117. PubMed ID: 31418365
[TBL] [Abstract][Full Text] [Related]
17. [Rapamycin Induces Apoptosis of K562 Cells through EZH2/Hedgehog Signaling Pathway].
He YX; Zhang HT; He PC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1402-1408. PubMed ID: 31607290
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of LY294002 and ABT199 on the cell cycle in K562, HL60 and KG1a cells.
Geng Y; Wu W; Zhou L; Li J; Geng Y; Yang Y
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846811
[TBL] [Abstract][Full Text] [Related]
19. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
20. [Telomerase activity,PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line].
Yu XX; Shi YA; Zhang LH; Wang YS; Wu S
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):323-7. PubMed ID: 18956651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
